Literature DB >> 8473740

Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.

E Bonfa1, V S Viana, A C Barreto, N H Yoshinari, W Cossermelli.   

Abstract

Sera from 102 patients with chronic Chagas' disease were studied for the presence of autoantibodies to intracellular proteins and nucleic acids by three different methods. Only four sera had autoantibodies detected by indirect immunofluorescence on HEp-2 cells. All of the sera were negative for anti-dsDNA, anti-Ro/SSA, anti-La/SSB, anti-Sm and anti-RNP autoantibodies but 12 (12%) of the sera had low to moderate levels of anti-histone antibodies. When Chagas sera were tested for autoantibodies to a total HeLa cell extract by Western blotting, weak reactivity was observed in 31 sera. Despite significant heterogeneity in the protein Ag targeted by these sera, seven recognized a 23-kDa protein. Strong binding to this 23 kDa protein was observed in one-third of the sera when isolated ribosomes were used as source of Ag. In contrast, no autoreactivity was detected with ribosomal proteins P0, P1, and P2. These findings confirm the presence of autoantibodies in chronic Chagas' disease and indicate a remarkable restricted humoral immune response to human ribosomal proteins. Furthermore, affinity-isolated anti-23-kDa antibody cross-reacted with a Trypanosoma cruzi ribosomal protein of similar molecular weight. This molecular mimicry may be responsible for the apparent breakdown of self-tolerance resulting in tissue damage. Indeed, experiments demonstrating that immunization of mice and rabbit with T. cruzi ribosomes have been reported to induce myocarditis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473740

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Infection, mimics, and autoimmune disease.

Authors:  N R Rose
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.

Authors:  N Gironès; C I Rodríguez; E Carrasco-Marín; R F Hernáez; J L de Rego; M Fresno
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 3.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  HLA class I and II profiles of patients presenting with Chagas' disease.

Authors:  N H Deghaide; R O Dantas; E A Donadi
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.

Authors:  M E Solana; A M Katzin; E S Umezawa; C S Miatello
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity.

Authors:  Kevin M Bonney; Joann M Taylor; Melvin D Daniels; Conrad L Epting; David M Engman
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

Review 7.  Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?

Authors:  Elidiana De Bona; Kárita Cláudia Freitas Lidani; Lorena Bavia; Zahra Omidian; Luiza Helena Gremski; Thaisa Lucas Sandri; Iara J de Messias Reason
Journal:  Front Immunol       Date:  2018-08-06       Impact factor: 7.561

8.  Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.

Authors:  I Ferrari; M J Levin; G Wallukat; R Elies; D Lebesgue; P Chiale; M Elizari; M Rosenbaum; J Hoebeke
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?

Authors:  Victor Garcia-Bustos; Pedro Moral Moral; Marta Dafne Cabañero-Navalon; Miguel Salavert Lletí; Eva Calabuig Muñoz
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.